<DOC>
	<DOC>NCT01287182</DOC>
	<brief_summary>This is a trial of Ateronon in Patients with Coronary Disease to Evaluate its Effectiveness in Assessing the Risk Factors of Atherosclerosis.</brief_summary>
	<brief_title>Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Men and Women with demonstrated Coronary Disease AtheroAbzyme positive during screening process Elevated Total Cholesterol Willingness to take study nutritional supplement once a day for 3 months Women who are pregnant, nursing or intend pregnancy during the period of treatment Known milk, soy or whey allergy</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Asymptomatic Myocardial Ischemic patients</keyword>
</DOC>